KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Inventory Average (2016 - 2025)

Abbott Laboratories' Inventory Average history spans 17 years, with the latest figure at $6.6 billion for Q4 2025.

  • For Q4 2025, Inventory Average rose 1.45% year-over-year to $6.6 billion; the TTM value through Dec 2025 reached $6.6 billion, up 1.45%, while the annual FY2025 figure was $6.3 billion, 0.64% down from the prior year.
  • Inventory Average for Q4 2025 was $6.6 billion at Abbott Laboratories, down from $6.8 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $6.8 billion in Q3 2025 and bottomed at $5.2 billion in Q1 2021.
  • The 5-year median for Inventory Average is $6.5 billion (2023), against an average of $6.2 billion.
  • The largest annual shift saw Inventory Average rose 18.42% in 2023 before it fell 4.21% in 2025.
  • A 5-year view of Inventory Average shows it stood at $5.2 billion in 2021, then grew by 14.29% to $6.0 billion in 2022, then increased by 11.03% to $6.6 billion in 2023, then fell by 1.61% to $6.5 billion in 2024, then increased by 1.45% to $6.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Inventory Average are $6.6 billion (Q4 2025), $6.8 billion (Q3 2025), and $6.8 billion (Q2 2025).